Jump to content

Talk:CureVac: Difference between revisions

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
Content deleted Content added
cc tag
Line 14: Line 14:
}}
}}
{{COI editnotice}}
{{COI editnotice}}

== Request edit on 8 May 2018 ==

<!-- PLEASE READ: Please provide your requested edit after the {{request edit}} below in a roughly "replace X with Y" format. Explain the rationale behind the edit and provide reliable sources to support the proposed changes. At the end of the request, add four tildes "~~~~" and click "Save Page" -->

{{request edit}}

I would like to request the following change: CureVac has entered into a collaboration with [[Eli Lilly and Company]] in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g.
https://endpts.com/eli-lilly-is-making-a-1-8b-leap-into-the-mrna-field-targeting-next-gen-cancer-vaccines/
and
https://www.fiercebiotech.com/biotech/lilly-curevac-pen-1-8b-mrna-cancer-vaccine-deal
Thank you for reviewing, --[[User:VerenaLauterbach CureVacAG|VerenaLauterbach CureVacAG]] ([[User talk:VerenaLauterbach CureVacAG|talk]]) 12:49, 8 May 2018 (UTC)

Revision as of 12:49, 8 May 2018

WikiProject iconArticles for creation Stub‑class
WikiProject iconThis article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.
StubThis article has been rated as Stub-class on Wikipedia's content assessment scale.
Note icon
This article was accepted on 25 April 2013 by reviewer Arthur goes shopping (talk · contribs).

Request edit on 8 May 2018

I would like to request the following change: CureVac has entered into a collaboration with Eli Lilly and Company in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g. https://endpts.com/eli-lilly-is-making-a-1-8b-leap-into-the-mrna-field-targeting-next-gen-cancer-vaccines/ and https://www.fiercebiotech.com/biotech/lilly-curevac-pen-1-8b-mrna-cancer-vaccine-deal Thank you for reviewing, --VerenaLauterbach CureVacAG (talk) 12:49, 8 May 2018 (UTC)[reply]